e-Drug3D

1817

EPHEDRINE


INN
EPHEDRINE

(has an active metabolite)

cas 299-42-3
CLASS

RESPIRATORY
SYMPATHOMIMETIC
ALPHA AND BETA ADRENERGIC AGONIST
NOREPINEPHRINE RELEASING AGENT
TREATMENT OF CLINICALLY IMPORTANT HYPOTENSION OCCURRING IN THE SETTING OF ANESTHESIA
METABOLIZED INTO NOREPHEDRINE

ROUTE (list)

INTRAVENOUS

NATURAL MOLECULE (link)

ATC code

C01CA26
R01AA03
R01AB05
R03CA02
S01FB02
A08AA56

PK parameters

t1/2 6 HOUR

Solubility

FREELY SOLUBLE IN WATER


Target

TARGET ALPHA ADRENERGIC RECEPTOR
BETA ADRENERGIC RECEPTOR

DrugCentral

Beta-2 adrenergic receptor UNIPROT P07550 ADRB2

Download SDF file Benzenemethanol, alpha-[(1S)-1-(methylamino)ethyl]-, (alphaR)-

Formula:
C10H15NO

Calculated chemical properties:

MW 165.23
NB_atoms 12
XLogP 1.33
PSA 32.155
NB_HD 2
NB_HA 2
fsp3 0.40
Lipinski(0=no;1=yes) 1

FDA
NDA 208289 (pdf not found) INN (EPHEDRINE SULFATE) AKOVAZ (EXELA PHARMA) APPROVAL= AP YEAR= 2016
NDA 208609 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (RENEW PHARMS) APPROVAL= AP YEAR= 2017 DISCONTINUED
NDA 208943 (pdf not found) INN (EPHEDRINE SULFATE) CORPHEDRA (PH HEALTH) APPROVAL= AP YEAR= 2017
NDA 209784 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (SANDOZ) APPROVAL= AP YEAR= 2017
NDA 212932 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (AMNEAL) APPROVAL= AP YEAR= 2019
NDA 213407 (pdf not found) INN (EPHEDRINE SULFATE) EMERPHED (NEXUS) APPROVAL= AP YEAR= 2020
NDA 209646 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2020
NDA 212649 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (DR REDDYS) APPROVAL= AP YEAR= 2020
NDA 213994 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (PH HEALTH) APPROVAL= AP YEAR= 2020
NDA 214334 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (HIKMA) APPROVAL= AP YEAR= 2020
NDA 213536 (pdf not found) INN (EPHEDRINE HYDROCHLORIDE) REZIPRES (DR REDDYS LABS SA) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 214579 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (EUGIA PHARMA) APPROVAL= AP YEAR= 2021
NDA 215825 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (XIROMED) APPROVAL= AP YEAR= 2022
NDA 216129 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (MANKIND PHARMA) APPROVAL= AP YEAR= 2022
NDA 216146 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (GLAND) APPROVAL= AP YEAR= 2022
NDA 214528 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2023
NDA 217276 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 217721 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (HIKMA) APPROVAL= AP YEAR= 2024
NDA 219050 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (CAPLIN) APPROVAL= AP YEAR= 2024
NDA 218211 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (GLAND) APPROVAL= AP YEAR= 2025
NDA 218271 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2025

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL